Rare diseases
Investigational molecules
Locations
Back to Poland77 clinical trials in Sopot, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA
PolandLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
PolandA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
PolandA study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
PolandA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
PolandA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
PolandA study testing duvakitug for patients with moderately to severely active ulcerative colitis
PolandStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
PolandStudy of SPN-817 (Huperzine A) in Adults with Focal Onset Seizures: Testing Safety and Effectiveness of Treatment
PolandStudy of PF-07328948 tablets compared to placebo in adults with heart failure to evaluate effects on symptoms and physical function
PolandStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
PolandThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on inflammatory bowel diseases, particularly investigating novel therapies for both Crohn's Disease and Ulcerative Colitis. Multiple trials are evaluating new treatment approaches for patients with moderate to severe conditions.
Studies aim to improve clinical remission rates and enhance patient outcomes through innovative therapeutic approaches.
Leading investigations into cardiovascular diseases and conditions, with particular emphasis on heart failure and atherosclerotic cardiovascular disease. Studies include both preserved and reduced ejection fraction heart failure trials.
Research focuses on improving cardiovascular outcomes and developing new therapeutic strategies for heart disease management.
Groundbreaking research in Alzheimer's Disease treatment and management, including studies of early-stage interventions and cognitive decline prevention. Multiple trials are exploring novel therapeutic approaches.
Investigations focus on developing effective treatments for early-stage Alzheimer's and related cognitive conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
